lobbying_activities: 2829075

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2829075	793123b9-5325-413f-bbbd-7d8a5f3f70af	Q2	RUBICON ADVISORS, LLC	315091	DYNAVAX TECHNOLOGIES	2022	second_quarter	PHA	Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA)	HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS)	75000		0	0	2022-07-19T11:43:43-04:00